Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2024-10-23 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance with Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It informs about the dispatch of a 'Letter of Confirmation' to a shareholder for the issue of a duplicate share certificate. The content is procedural and regulatory in nature, related to share certificate issuance and compliance, not a financial report or earnings release. It does not contain financial statements, management discussion, or audit information. It is also not a report publication announcement or a proxy solicitation. The document is best classified as a Regulatory Filing (RNS) because it is a compliance-related announcement to the stock exchanges that does not fit into other specific categories.
2024-10-23 English
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is an official communication from Strides Pharma Science Limited to stock exchanges regarding the issuance of a duplicate share certificate due to loss of the original certificate by a shareholder. It references compliance with SEBI regulations and includes details about the shareholder and certificate. The content is an announcement related to share certificate issuance, not a financial report, earnings release, or management discussion. It does not contain financial statements or analysis. This fits the category of Share Issue/Capital Change (SHA) because it involves changes related to share certificates and capital records. The document length is short and focused on this specific procedural update, confirming it is not a full report or announcement of a report publication.
2024-10-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2024-10-18 English
Board Meeting — STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 24-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Compan…
Regulatory Filings
2024-10-18 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short announcement addressed to stock exchanges regarding a scheduled Board Meeting to consider and approve un-audited financial results for a specific quarter and half year period. It also mentions the closure of the trading window for insiders. The document does not contain any financial data or detailed report content but is an announcement of an upcoming event related to financial results. The length is only 1360 characters, indicating it is a brief notice rather than a full report. Therefore, it fits the category of Board/Management Information (MANG), as it announces a board meeting and related procedural information.
2024-10-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges regarding the issuance of a duplicate share certificate due to loss or misplacement of the original certificate by a shareholder. It references compliance with SEBI regulations and includes details of the shareholder and share certificate. The document is a notification about a share certificate issue, not a financial report, earnings release, or management discussion. It does not contain financial statements or analysis. It is a regulatory announcement related to shareholding records and procedural compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.